Literature DB >> 6249487

Treatment of feline leukemia and reversal of FeLV by ex vivo removal of IgG: a preliminary report.

F R Jones, L H Yoshida, W C Ladiges, M A Kenny.   

Abstract

Cats that were spontaneously infected with feline leukemia virus (FeLv) were treated with a combination of low-dose irradiation and extracorporeal immunosorption using formalin and heat-fixed S. aureus as a non-specific immunosorbent to remove plasma IgG and immune complexes. The treatment resulted in reduction of circulating lymphoblasts within two weeks and clinical improvement of three of the five animals. A reversal of the FeLV status is reported in five of five cats. Two of the five cats remain FeLV negative and completely tumor free seven and eight months post-therapy at the time of writing (July 1979). A third cat returned to an FeLV positive state but remained tumor free for 24 weeks. Another cat responded to the therapy by reduction of lymphoblasts and became FeLV negative but died of a hemorrhage during an immunosorption. The last cat's status was FeLV positive, then FeLV negative, and finally FeLV positive again. He died 20 weeks after initiation of therapy. During the treatment there was a weight gain in the three cats responding by tumor regression. The results are discussed in terms of a removal of some type of immunoinhibiting factors such as antigen-antibody complexes or suppressor molecules.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6249487     DOI: 10.1002/1097-0142(19800815)46:4<675::aid-cncr2820460408>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

Review 1.  Feline leukemia virus: current status of the feline induced immune depression and immunoprevention.

Authors:  R G Olsen; M G Lewis; L J Lafrado; L E Mathes; K Haffer; R Sharpee
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  FeLV Infection, Hemolytic Anemia and Hypocellular Bone Marrow in a Cat: Treatment with Protein A and Prednisone.

Authors:  M E Hitt; D L McCaw
Journal:  Can Vet J       Date:  1988-09       Impact factor: 1.008

3.  Correlation between surface morphology and surface forces of protein A adsorbed on mica.

Authors:  S Ohnishi; M Murata; M Hato
Journal:  Biophys J       Date:  1998-01       Impact factor: 4.033

Review 4.  Immunopathology induced by the feline leukemia virus.

Authors:  W D Hardy
Journal:  Springer Semin Immunopathol       Date:  1982

Review 5.  Suppressor mechanisms in tumor immunity.

Authors:  G T Nepom; I Hellström; K E Hellström
Journal:  Experientia       Date:  1983-03-15

6.  Immunologic enhancement of experimental metastasis in the rat.

Authors:  J R Starkey; S S Ristow; T L McDonald; J E Talmadge
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Appearance of cytotoxic antibody to viral gp70 on feline lymphoma cells (FL-74) in cats during ex vivo immunoadsorption therapy: quantitation, characterization, and association with remission of disease and disappearance of viremia.

Authors:  W T Liu; R W Engelman; L Q Trang; K Hau; R A Good; N K Day
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

8.  Treatment of advanced malignancy with plasma perfused over staphylococcal protein A.

Authors:  F R MacKintosh; K Bennett; S Schiff; J Shields; S W Hall
Journal:  West J Med       Date:  1983-07

9.  Antitumor activity with nontoxic doses of protein A.

Authors:  P K Ray; S Bandyopadhyay; M Dohadwala; P Canchanapan; J Mobini
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

10.  Detection of tumour associated antigen in eluates from protein A columns used for ex vivo immunoadsorption of plasma from melanoma patients by radioimmunoassay.

Authors:  R K Gupta; A M Leitch; D L Morton
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.